• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,755.05 -715.06
( -0.92%)
Global Indices
Nasdaq
52,245.67 385.41
(0.74%)
Dow Jones
7,529.66 65.38
(0.88%)
Hang Seng
66,164.55 -67.64
(-0.10%)
Nikkei 225
10,722.03 136.12
(1.29%)
Forex
USD-INR
96.43 0.01
(0.01%)
EUR-INR
110.17 -0.09
(-0.08%)
GBP-INR
129.67 0.03
(0.02%)
JPY-INR
0.59 0.00
(0.01%)

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524715
INE044A01036
93.2373503
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SUNPHARMA
159.91
470785.51
EPS(TTM)
Face Value()
Div & Yield %
12.27
1
0.82
 

20 Microns consolidated net profit rises 15.77% in the March 2026 quarter
May 22,2026
Net profit of 20 Microns rose 15.77% to Rs 17.62 crore in the quarter ended March 2026 as against Rs 15.22 crore during the previous quarter ended March 2025. Sales rose 14.80% to Rs 261.06 crore in the quarter ended March 2026 as against Rs 227.41 crore during the previous quarter ended March 2025.

For the full year,net profit rose 7.13% to Rs 66.83 crore in the year ended March 2026 as against Rs 62.38 crore during the previous year ended March 2025. Sales rose 4.50% to Rs 953.83 crore in the year ended March 2026 as against Rs 912.79 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales261.06227.41 15 953.83912.79 5
OPM %12.1012.68 -12.8512.86 -
PBDT29.7624.29 23 111.63103.00 8
PBT24.5819.33 27 91.1184.74 8
NP17.6215.22 16 66.8362.38 7